HBAN
82
2
TROW
61
2
STZ
49
2
KO
44
2
ALL
61
-2
EXC
53
3
RF
63
2
HPE
68
-5
NKE
36
6
ADT
48
2
DUK
59
4
LOW
45
2
D
45
4
OMC
55
-7
XYL
35
2
COST
53
5
ZBH
45
3
GT
39
2
STI
15
-6
PX
55
2
HBAN
82
2
TROW
61
2
STZ
49
2
KO
44
2
ALL
61
-2
EXC
53
3
RF
63
2
HPE
68
-5
NKE
36
6
ADT
48
2
DUK
59
4
LOW
45
2
D
45
4
OMC
55
-7
XYL
35
2
COST
53
5
ZBH
45
3
GT
39
2
STI
15
-6
PX
55
2
Financhill
Back

Meritage Homes Corp. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
51

MTH
Meritage Homes Corp.

Last Price:
$66.51
Seasonality Move:
6.48%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Buy
51
Meritage Homes Corp. (MTH) is a Buy

Is Meritage Homes Corp. a Buy, Sell or Hold?

  • The current Meritage Homes Corp. [MTH] share price is $66.56. The Score for MTH is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • MTH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MTH Stock Price Chart

What is Meritage Homes Corp.'s stock price today?

  • The Meritage Homes Corp. share price today is $66.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTH is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

MTH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.93 Sell
Relative Strength Index (14 RSI): 39.77 Sell
Chaikin Money Flow: 132429 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (67.38 - 73.12) Sell
Bollinger Bands (100): (67.74 - 76.52) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

MTH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 67.73 Sell
20-day SMA: 70.57 Sell
50-day SMA: 69.26 Sell
200-day SMA: 70.14 Sell
8-day EMA: 67.57 Sell
20-day EMA: 69.01 Sell
50-day EMA: 69.82 Sell
200-day EMA: 72.3 Sell

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Meritage Homes Corp. Earnings Growth & MTH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.87 per share, and an increase next year of $0.29 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Meritage Homes Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):